Evidence map›Paper›PMID 41952355›Full record

ArticleActa obstetricia et gynecologica Scandinavica2026

Subsequent pregnancies after a diagnosis of pregnancy-associated cancer.

Giovanna Esposito, Fedro Alessandro Peccatori, Matteo Franchi, Giuseppe Trojano, Giovanni Corrao, Carlo La Vecchia, Fabio Parazzini, Anna Cantarutti

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giovanna EspositoDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.ORCID 0000-0001-7894-4456
Fedro Alessandro PeccatoriDepartment of Gynecology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
Matteo FranchiUnit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Giuseppe TrojanoDepartment of Maternal and Child Health, Madonna Delle Grazie Hospital, Matera, Italy.
Giovanni CorraoEmeritus Professor of Medical Statistic, University of Milano-Bicocca, Milan, Italy.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.ORCID 0000-0003-1441-897X
Fabio ParazziniDepartment of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.
Anna CantaruttiUnit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

Funding

European Union-Next Generation EU
6 · The paper itself

Abstract

introductionPregnancy-associated cancer is a rare but clinically significant event. Decisions regarding subsequent pregnancies after such a diagnosis are complex and influenced by medical, psychological, and social factors. This study aimed to investigate the probability of having a subsequent pregnancy following a diagnosis of a pregnancy-associated cancer. MATERIAL AND

methodsWe conducted a record-linkage cohort study using the regional health databases of Lombardy, including the hospital discharge records and the certificate of delivery assistance. Pregnancies were deliveries and abortions occurring between 1 January 2007 and 31 December 2017. Pregnancy-associated cancer was defined as any malignant neoplasm first diagnosed during pregnancy or within 1 year after the end of pregnancy, identified through hospital admissions carrying a new cancer diagnosis. To ascertain subsequent pregnancies after a diagnosis of pregnancy-associated cancer, we tracked deliveries and abortions through 31 December 2023. We estimated the incidence of pregnancy-associated cancer per 1000 pregnancies with the corresponding 95% confidence intervals (CIs) and calculated the cumulative probability of a post-diagnosis pregnancy using the cumulative incidence function that accounts for the competing risk of death.

resultsA total of 832 incident pregnancy-associated cancers were recorded among deliveries and 325 among abortions, corresponding to incidence rates of 1.12 per 1000 deliveries (95% CI, 1.04-1.19) and 1.27 per 1000 abortions (95% CI, 1.13-1.41). Breast cancer was the most frequent diagnosis in both groups (31% among deliveries, 40% among abortions), followed by thyroid cancer; the third most common site was lymphoma among deliveries and cervical cancer among abortions. During follow-up, 77 women had a subsequent pregnancy (59 deliveries, 18 abortions), yielding a cumulative probability of 7.3%. Stratified by age at diagnosis, women under 35 had a substantially higher probability of subsequent pregnancy compared to women aged 35 or older (14.0% vs. 3.5%, p < 0.01). Furthermore, the cumulative probability of subsequent pregnancy was lower among women treated with antineoplastic therapy than among those who were not treated (4.3% vs. 10.1%, p < 0.01).

conclusionsSubsequent pregnancies following a pregnancy-associated cancer diagnosis were relatively uncommon, highlighting the need for integrated reproductive counseling within a multidisciplinary approach.

Indexed as

NeoplasmsPregnancy Complications, NeoplasticAbortion, InducedAdultCohort StudiesFemaleHumansIncidenceItalyPregnancyfertility counselingmaternal healthpregnancy‐associated cancerreproductive outcomessubsequent pregnancy

Identifiers

PMID41952355
PMCPMC13191814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.